| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,057 |
7,182 |
$559K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,979 |
1,936 |
$166K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,700 |
5,367 |
$166K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,691 |
1,655 |
$146K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,009 |
2,800 |
$137K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,145 |
1,077 |
$102K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,150 |
1,107 |
$87K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,714 |
4,544 |
$65K |
| 92552 |
|
3,526 |
3,397 |
$50K |
| 3008F |
|
7,767 |
7,316 |
$31K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,072 |
2,001 |
$25K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
578 |
527 |
$15K |
| 90461 |
|
208 |
193 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
962 |
944 |
$6K |
| 99173 |
|
3,567 |
3,446 |
$6K |
| 90686 |
|
1,358 |
1,242 |
$5K |
| 90656 |
|
204 |
203 |
$4K |
| 94010 |
|
247 |
239 |
$4K |
| 90619 |
|
145 |
133 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,149 |
1,133 |
$3K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,097 |
3,061 |
$3K |
| 90671 |
|
18 |
18 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
391 |
384 |
$2K |
| 90670 |
|
249 |
229 |
$2K |
| 90473 |
|
133 |
132 |
$2K |
| 0071A |
|
46 |
46 |
$2K |
| 83655 |
|
244 |
238 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
166 |
155 |
$2K |
| 0072A |
|
42 |
42 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
80 |
74 |
$2K |
| 85018 |
|
1,506 |
1,443 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
102 |
95 |
$1K |
| 90698 |
|
468 |
438 |
$1K |
| 36416 |
|
820 |
813 |
$912.06 |
| 90715 |
|
61 |
59 |
$387.01 |
| 90680 |
|
100 |
92 |
$369.20 |
| 97802 |
|
3,806 |
3,755 |
$292.78 |
| 90677 |
|
167 |
161 |
$270.05 |
| 90734 |
|
22 |
18 |
$225.15 |
| 90633 |
|
130 |
107 |
$164.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
13 |
$110.74 |
| A4614 |
Peak expiratory flow rate meter, hand held |
110 |
109 |
$74.12 |
| 99072 |
|
530 |
498 |
$0.00 |
| 99401 |
|
25 |
25 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
668 |
562 |
$0.00 |
| 90651 |
|
36 |
29 |
$0.00 |
| 90744 |
|
14 |
12 |
$0.00 |